Birdwatch Note
2024-10-12 10:46:44 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
ヨモギの一種、青蒿から分離・精製した薬剤アルテスネイトはさまざまながん細胞に対して抗腫瘍効果を示すことが報告されていますが、「抗がん作用がある」というのはごく限られた条件の中での実験です。 https://www.embopress.org/doi/full/10.15252/emmm.202216959 https://patents.google.com/patent/JP4339699B2/ja https://osaka.krg.or.jp/treatment/artesunate/ https://cyuoh-ah.jp/blog/2195/ https://osaka.krg.or.jp/treatment/artesunate/ そのためヨモギ・それで作ったお茶を飲食しても効果がありませんし、科学的根拠はないです。 またキク科のアレルギーをお持ちの方は注意が必要です。 https://banno-clinic.biz/artemisia-pollen-allergy/
Written by 1EE85F72355851C87FDDE84506361E48C52AAB618F239EC99E1F5839BA5B0BF4
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1845028211928990170
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1845053481956278447
- noteId - 1845053481956278447
- participantId -
- noteAuthorParticipantId - 1EE85F72355851C87FDDE84506361E48C52AAB618F239EC99E1F5839BA5B0BF4 Participant Details
- createdAtMillis - 1728730004192
- tweetId - 1845028211928990170
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- ヨモギの一種、青蒿から分離・精製した薬剤アルテスネイトはさまざまながん細胞に対して抗腫瘍効果を示すことが報告されていますが、「抗がん作用がある」というのはごく限られた条件の中での実験です。 https://www.embopress.org/doi/full/10.15252/emmm.202216959 https://patents.google.com/patent/JP4339699B2/ja https://osaka.krg.or.jp/treatment/artesunate/ https://cyuoh-ah.jp/blog/2195/ https://osaka.krg.or.jp/treatment/artesunate/ そのためヨモギ・それで作ったお茶を飲食しても効果がありませんし、科学的根拠はないです。 またキク科のアレルギーをお持ちの方は注意が必要です。 https://banno-clinic.biz/artemisia-pollen-allergy/
Note Ratings
rated at | rated by | |
2024-10-12 20:07:18 -0500 | Rating Details | |
2024-10-12 19:32:07 -0500 | Rating Details | |
2024-10-12 18:23:22 -0500 | Rating Details | |
2024-10-12 18:10:24 -0500 | Rating Details | |
2024-10-12 10:41:42 -0500 | Rating Details | |
2024-10-12 08:37:40 -0500 | Rating Details | |
2024-10-12 08:24:07 -0500 | Rating Details | |
2024-10-12 07:01:24 -0500 | Rating Details | |
2024-10-12 06:58:51 -0500 | Rating Details | |
2024-10-12 06:56:24 -0500 | Rating Details | |
2024-10-12 06:50:47 -0500 | Rating Details | |
2024-10-12 06:32:54 -0500 | Rating Details | |
2024-10-12 06:28:32 -0500 | Rating Details | |
2024-10-12 06:20:02 -0500 | Rating Details | |
2024-10-13 16:35:13 -0500 | Rating Details | |
2024-10-13 01:50:10 -0500 | Rating Details | |
2024-10-12 20:04:42 -0500 | Rating Details | |
2024-10-12 19:44:27 -0500 | Rating Details | |
2024-10-12 19:02:47 -0500 | Rating Details | |
2024-10-12 18:31:59 -0500 | Rating Details | |
2024-10-12 18:30:21 -0500 | Rating Details | |
2024-10-12 18:01:32 -0500 | Rating Details | |
2024-10-12 17:09:39 -0500 | Rating Details | |
2024-10-12 14:48:47 -0500 | Rating Details | |
2024-10-12 12:25:53 -0500 | Rating Details | |
2024-10-12 07:59:33 -0500 | Rating Details | |
2024-10-12 06:35:02 -0500 | Rating Details | |
2024-10-12 06:34:51 -0500 | Rating Details | |
2024-10-12 06:30:45 -0500 | Rating Details | |
2024-10-12 06:27:28 -0500 | Rating Details | |
2024-10-14 14:57:24 -0500 | Rating Details | |
2024-10-13 11:33:24 -0500 | Rating Details | |
2024-10-12 22:10:07 -0500 | Rating Details | |
2024-10-12 20:25:58 -0500 | Rating Details | |
2024-10-12 20:10:25 -0500 | Rating Details | |
2024-10-12 18:35:18 -0500 | Rating Details | |
2024-10-12 08:32:30 -0500 | Rating Details | |
2024-10-12 06:48:34 -0500 | Rating Details | |
2024-10-12 06:46:47 -0500 | Rating Details | |
2024-10-12 06:46:43 -0500 | Rating Details | |
2024-10-12 06:46:09 -0500 | Rating Details | |
2024-10-12 06:37:11 -0500 | Rating Details | |
2024-10-12 06:35:18 -0500 | Rating Details | |
2024-10-12 06:34:10 -0500 | Rating Details | |
2024-10-12 06:32:25 -0500 | Rating Details | |
2024-10-12 06:31:29 -0500 | Rating Details | |
2024-10-14 17:05:08 -0500 | Rating Details | |
2024-10-13 10:13:54 -0500 | Rating Details | |
2024-10-12 20:50:39 -0500 | Rating Details | |
2024-10-12 18:55:35 -0500 | Rating Details | |
2024-10-12 18:49:26 -0500 | Rating Details | |
2024-10-12 18:31:15 -0500 | Rating Details | |
2024-10-12 08:48:49 -0500 | Rating Details | |
2024-10-12 06:38:04 -0500 | Rating Details | |
2024-10-12 06:37:03 -0500 | Rating Details | |
2024-10-12 06:36:16 -0500 | Rating Details | |
2024-10-12 06:34:24 -0500 | Rating Details | |
2024-10-12 06:34:21 -0500 | Rating Details | |
2024-10-12 06:33:36 -0500 | Rating Details | |
2024-10-12 06:33:23 -0500 | Rating Details | |
2024-10-12 06:30:13 -0500 | Rating Details | |
2024-10-12 06:03:02 -0500 | Rating Details | |
2024-10-15 04:02:11 -0500 | Rating Details | |
2024-10-13 01:24:26 -0500 | Rating Details | |
2024-10-13 00:10:44 -0500 | Rating Details | |
2024-10-12 23:48:08 -0500 | Rating Details | |
2024-10-12 19:03:48 -0500 | Rating Details | |
2024-10-12 18:54:00 -0500 | Rating Details | |
2024-10-12 18:30:11 -0500 | Rating Details | |
2024-10-12 17:17:32 -0500 | Rating Details | |
2024-10-12 08:43:56 -0500 | Rating Details | |
2024-10-12 08:19:41 -0500 | Rating Details | |
2024-10-12 08:05:41 -0500 | Rating Details | |
2024-10-12 07:49:44 -0500 | Rating Details | |
2024-10-12 06:43:55 -0500 | Rating Details | |
2024-10-12 06:34:46 -0500 | Rating Details | |
2024-10-12 06:34:37 -0500 | Rating Details | |
2024-10-12 06:29:01 -0500 | Rating Details | |
2024-10-12 06:15:10 -0500 | Rating Details |